Cargando…

Long-term efficacy and safety outcomes with OROS-MPH in adults with ADHD

Methylphenidate (MPH) is widely prescribed for adults with attention deficit hyperactivity disorder (ADHD), but data on long-term treatment and maintenance of effect are lacking. Osmotic release oral system-methylphenidate (OROS–MPH) was evaluated in a 52-wk open-label study in subjects who had prev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buitelaar, Jan K., Trott, Götz-Erik, Hofecker, Maria, Waechter, Sandra, Berwaerts, Joris, Dejonkheere, Joachim, Schäuble, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2012
Materias:	Thematic Section: Attention-Deficit Hyperactivity Disorder (ADHD)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3243903/ https://www.ncbi.nlm.nih.gov/pubmed/21798108 http://dx.doi.org/10.1017/S1461145711001131

Ejemplares similares

ADHD, Methylphenidate, and Childhood Epilepsy
por: Sharma, Rahul, et al.
Publicado: (2016)

ADHD as Sequel to Acute Disseminated Encephalomyelitis
por: Millichap, J. Gordon
Publicado: (2016)

Indications for an EEG in a Child with ADHD
por: Millichap, J. Gordon, et al.
Publicado: (2015)

Atomoxetine/Methylphenidate Effects on Social Play Behavior
por: Millichap, J. Gordon
Publicado: (2015)

Enhancing ADHD Medication Adherence: Challenges and Opportunities
por: Charach, Alice, et al.
Publicado: (2013)

Attention-Deficit/Hyperactivity Disorder (ADHD) and Obesity: Update 2016
por: Cortese, Samuele, et al.
Publicado: (2017)

Neurofeedback as a Treatment Intervention in ADHD: Current Evidence and Practice
por: Enriquez-Geppert, Stefanie, et al.
Publicado: (2019)

Familial co-aggregation of attention-deficit/hyperactivity disorder and autoimmune diseases: a cohort study based on Swedish population-wide registers
por: Hegvik, Tor-Arne, et al.
Publicado: (2021)

Decline in attention-deficit hyperactivity disorder traits over the life course in the general population: trajectories across five population birth cohorts spanning ages 3 to 45 years
por: Wootton, Robyn E, et al.
Publicado: (2022)

Fetal Alcohol Exposure and Attention: Moving Beyond ADHD
por: Coles, Claire D.
Publicado: (2001)

Dystonia with MPH/Risperidone Combined Therapy for ADHD
por: Millichap, J. Gordon, et al.
Publicado: (2016)

Association of maternal diabetes with neurodevelopmental disorders: autism spectrum disorders, attention-deficit/hyperactivity disorder and intellectual disability
por: Chen, Shuyun, et al.
Publicado: (2020)

Early-life antibiotic use and risk of attention-deficit hyperactivity disorder and autism spectrum disorder: results of a discordant twin study
por: Slob, Elise M A, et al.
Publicado: (2020)

Maternal type 1 diabetes, pre-term birth and risk of autism spectrum disorder–a prospective cohort study
por: Persson, Martina, et al.
Publicado: (2022)

Mendelian randomization analysis for attention deficit/hyperactivity disorder: studying a broad range of exposures and outcomes
por: Soler Artigas, María, et al.
Publicado: (2022)

Improved functionality, health related quality of life and decreased burden of disease in patients with ADHD treated with OROS(® )MPH: is treatment response different between children and adolescents?
por: Berek, Michael, et al.
Publicado: (2011)

Switching from Methylphenidate-Immediate Release (MPH-IR) to Methylphenidate-OROS (OROS-MPH): A Multi-center, Open-label Study in Korea
por: Kim, Bung-Nyun, et al.
Publicado: (2011)

Universal Social Protection and Health Care as a Social Common
por: Mestrum, Francine
Publicado: (2020)

Corporate Food Paradigms and Health Crisis: The Image of a Syndemic Crash
por: Salcedo Fidalgo, Hernando
Publicado: (2020)

Radical Approaches During Unusual Circumstances: Intellectual Property Regulation and the COVID-19 Dilemma
por: El Said, Mohammed
Publicado: (2020)

COVID-19 and Private Health: Market and Governance Failure
por: Williams, Owain David
Publicado: (2020)

Politics of International Health in the Bush Administration
por: Waxman, Henry A
Publicado: (2004)

Claiming Health as a Public Good in the Post-COVID-19 Era
por: Abdalla, Salma M., et al.
Publicado: (2020)

Between Tech and Trade, the Digital Turn in Development Policies
por: Al Dahdah, Marine, et al.
Publicado: (2020)

COVID-19 Pandemic Recession and Recovery
por: Jomo, K. S., et al.
Publicado: (2020)

A Volatile Context: A Revisionist Lens on Good Governance
por: Zuber, Robert
Publicado: (2021)

Negotiating Boundaries of Power in the Global Governance for Care
por: Durano, Marina
Publicado: (2021)

Slaying the New Dragons that Threaten Peace: Renewing the UN's ‘Systemic Issues’ Agenda
por: Montes, Manuel F.
Publicado: (2021)

A Trade Agenda for the Right to Food
por: Fakhri, Michael
Publicado: (2021)

Refusal as Radical Care? Moving Beyond Modern Industrial Agriculture
por: Arora, Saurabh, et al.
Publicado: (2021)

Global Food Governance
por: McKeon, Nora
Publicado: (2021)

Re-imagining the UN Committee on World Food Security
por: Guttal, Shalmali
Publicado: (2021)

Towards Building Comprehensive Legal Frameworks for Corporate Accountability in Food Governance
por: Dorado, Daniel, et al.
Publicado: (2021)

On the Non-reception of the Food Systems Summit in Europe
por: van der Ploeg, Jan Douwe
Publicado: (2021)

The Food Systems Summit’s Failure to Address Corporate Power
por: Clapp, Jennifer, et al.
Publicado: (2021)

Global Food Governance
por: McKeon, Nora
Publicado: (2021)

UN Food System Summit Fails to Address Real Healthy and Sustainable Diets Challenges
por: Coutinho, Janine Giuberti, et al.
Publicado: (2021)

Woke Science and the 4th Industrial Revolution: Inside the Making of UNFSS Knowledge
por: Montenegro de Wit, Maywa, et al.
Publicado: (2021)

The Climate Finance Conundrum
por: Chowdhury, Anis, et al.
Publicado: (2022)

Getting to COP27: Bridging Generational Divide
por: Stanczyk, Anna
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k45hkc15596jdnm8c1kbn2qguo